不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.
A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
慢性淋巴细胞白血病(CLL)是美国最常见的白血病,主要影响老年人。CLL 的特征是体能低下、免疫力下降以及继发恶性肿瘤和感染的风险增加。改善 CLL 患者体能和免疫功能的一种途径可能是参加结构化的运动计划。本初步研究旨在考察为期 12 周的高强度间歇训练(HIIT)结合肌肉耐力型抗阻训练在未经治疗的老年 CLL 患者中的身体和免疫学变化及可行性。
我们招募了 18 名年龄为 64.9±9.1 岁的 CLL 患者,并根据其居住地与我们健身中心的距离进行分组。10 名参与者(4 男/6 女)完成了 HIIT,6 名参与者(4 男/2 女)完成了非运动对照组(Controls)。HIIT 包括每周三次 30 分钟的跑步机训练,外加每周两次同时进行的 30 分钟力量训练。身体和免疫学结局指标包括有氧能力、肌肉力量和耐力,以及自然杀伤(NK)细胞对肿瘤细胞的识别和杀伤。如果 > 70% 的 HIIT 参与者完成了 > 75% 的规定训练次数和规定分钟数,且 > 80% 的高强度间歇心率达到至少 80% 峰值有氧能力(VO 2peak)对应的心率,我们即确认其可行性。
结果以 Hedge's G 效应量(g)表示,0.2、0.5 和 0.8 分别代表小、中、大效应。HIIT 后,腿部力量(g = 2.52)、胸部力量(g = 1.15)和坐姿划船力量(g = 3.07)分别比对照组高 35.4%、56.1% 和 39.5%,而有氧能力比对照组低 3.8%(g = 0.49)。同样,HIIT 后,体外 NK 细胞对 K562 细胞系(g = 1.43)、OSU-CLL 细胞系(g = 0.95)和自体 B 细胞(g = 1.30)的细胞溶解活性分别比对照组高 20.3%、3.0% 和 14.6%。可行性得以实现,HIIT 完成了 5.0 0.2 次/周和 99 3.6% 的规定分钟数/周,心率对应于 89 2.8% 的 VO 2peak。
我们证明,为期 12 周的监督下 HIIT 结合基于肌肉耐力的抗阻训练是可行的,且高依从性和顺应性与治疗初治的老年 CLL 患者肌肉力量和免疫功能的大幅改善相关。试验注册号:NCT04950452。
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the USA, affecting predominantly older adults. CLL is characterized by low physical fitness, reduced immunity, and increased risk of secondary malignancies and infections. One approach to improving CLL patients' physical fitness and immune functions may be participation in a structured exercise program.
The aims of this pilot study were to examine physical and immunological changes, and feasibility of a 12-week high-intensity interval training (HIIT) combined with muscle endurance-based resistance training on older adults with treatment na ve CLL.
We enrolled eighteen participants with CLL aged 64. 9 9. 1 years and assigned them to groups depending on distance lived from our fitness center. Ten participants (4 M/6F) completed HIIT and six participants (4 M/2F) completed a non-exercising control group (Controls). HIIT consisted of three 30-min treadmill sessions/week plus two concurrent 30-min strength training sessions/week. Physical and immunological outcomes included aerobic capacity, muscle strength and endurance, and natural killer (NK) cell recognition and killing of tumor cells.
We confirmed feasibility if > 70% of HIIT participants completed > 75% of prescribed sessions and prescribed minutes, and if > 80% of high-intensity intervals were at a heart rate corresponding to at least 80% of peak aerobic capacity (VO 2peak ). Results are presented as Hedge's G effect sizes (g), with 0. 2, 0. 5 and 0. 8 representing small, medium and large effects, respectively. Following HIIT, leg strength (g = 2. 52), chest strength (g = 1. 15) and seated row strength (g = 3. 07) were 35. 4%, 56. 1% and 39.
5% higher than Controls, respectively, while aerobic capacity was 3. 8% lower (g = 0. 49) than Controls. Similarly, following HIIT, in vitro NK-cell cytolytic activity against the K562 cell line (g = 1. 43), OSU-CLL cell line (g = 0. 95), and autologous B-cells (g = 1. 30) were 20. 3%, 3. 0% and 14. 6% higher than Controls, respectively. Feasibility was achieved, with HIIT completing 5. 0 0. 2 sessions/week and 99 3. 6% of the prescribed minutes/week at heart rates corresponding to 89 2. 8% of VO 2peak .
We demonstrate that 12-weeks of supervised HIIT combined with muscle endurance-based resistance training is feasible, and that high adherence and compliance are associated with large effects on muscle strength and immune function in older adults with treatment na ve CLL. Trial registration: NCT04950452.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。